GL1X · GenesisL1 explorer

MolNFT v1 · #167950 · protein

Structure of khk in complex with compound 2

6W0N · Ketohexokinase: “Structure of khk in complex with compound 2”. X-ray diffraction, 2 ligands (RYS, SO4), 5 pockets (best druggability 0.77). MolNFT v1 #167950 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6W0N
Type
protein
Length
597 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ketohexokinase
EC
2.7.1.3
UniProt
P50053
Ligands
RYS, SO4
Pockets
5 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 37% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AKetohexokinase (EC 2.7.1.3)protein29637% helix, 25% strandP50053
BKetohexokinase (EC 2.7.1.3)protein30136% helix, 25% strandP50053

Ligands and binding sites

  • RYS · 6-[(3~{S},4~{R})-3,4-bis(oxidanyl)pyrrolidin-1-yl]-2-[(3~{S})-3-methyl-3-oxidanyl-pyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A, B
  • CIT · Citric acid · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16340.770.8364RYS, SO4, CIT
27300.730.7971RYS, SO4
3630.530.8723empty
41330.420.7520empty
5720.380.7817empty

Interfaces

1 interface between chains.

  • A–B · 1677 Ų buried · 36 hydrogen bonds · protein-protein

Compared structures

  • 6W0N · Structure of KHK in complex with compound 2 · the same entry in another collection · chain A against A, TM-score 1.00
  • P50053 · AlphaFold monomer V2.0 prediction for ketohexokinase (P50053) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.